Results for:(32 found)
Mar 26, 2014 9:43PM on Top StocksBy MSN Money producer

One of the names on Morgan Stanley's list could be the next multibillion dollar acquisition.

Mar 20, 2014 1:00PM on Top StocksBy StreetAuthority

Applying a pairs trade to these movie studios could lead to solid gains.

Dec 4, 2013 4:13PM on TechBizBy Benzinga

The Internet giant purchased the startup -- and, perhaps as importantly, its personnel -- from DreamWorks Animation in CEO Marissa Mayer's latest 'acquire-hire' move.

Oct 30, 2013 12:24PM on Top StocksBy StreetAuthority

Mid-caps offer a unique combination of growth and stability, and these stocks are hitting especially hard on the growth front.

Oct 28, 2013 6:30AM on Top StocksBy Benzinga

This week's highlights include quarterly reports from the two biggest companies by market capitalization, Apple and Exxon Mobil, which are expect to post declining earnings.

Sep 23, 2013 10:39AM on Top StocksBy MSN Money Partner

DreamWorks is downgraded to 'neutral,' and Splunk is initiated with a 'neutral.'

Sep 19, 2013 10:15AM on Top StocksBy MSN Money Partner

Disney is downgraded to 'equal weight,' and Pandora is initiated with a 'fair value.'

Jul 22, 2013 3:18PM on Top StocksBy Benzinga

The relatively low-budget horror flick set a box office record in its category this weekend, beating out some movies with monstrous production costs.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

This stock is up nearly 300%

Puma Biotechnology shares soar after it says it wants to file for marketing approval of an experimental breast cancer drug.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More